Study of the Effect of Amlodipine, Atenolol, Enalapril and Losartan in Patients with Mild to Moderate Hypertension
Journal Title: International journal of Emerging Trends in Science and Technology - Year 2015, Vol 2, Issue 8
Abstract
Objectives: To evaluate and compare the efficacy and tolerability of amlodipine, atenolol, enalapril and losartan in patients with mild to moderate hypertension. Research design and method: This study was conducted in medicine department of tertiary care teaching hospital. This was prospective, open labelled, observational, randomized controlled clinical trial. Patients aged 30-60 years, newly diagnosed as mild to moderate hypertension were enrolled in the study. Pretreatmentevaluation of all the patients was done. Detailed clinical history, physical examination and routine laboratory investigations were done. Eligible patients were randomized to receive Amlodipine 2.5/5 mg, Atenolol 25/ 50 mg, Enalapril5/ 10 mg, Losartan 25/50 mg and followed them for 12 weeks, patient’svisits scheduled at 2 weeks interval. Primary efficacy end point was reduction in mean systolic blood pressure (SBP) and mean diastolic blood pressure (DBP). Safety was assessed in terms of systemic adverse events both subjective and objective (clinical and biochemical examinations). Results: Total 154 patients were enrolled, patients’ demographic and baseline clinical characteristics were comparable in all treatment groups. After 12 weeks of treatment the reduction in mean systolic blood pressure were 22.55±7.74, 21±7.94, 20.35±5.48, 22.61±8.41. Reduction in mean diastolic blood pressure were 13.11±4.31, 10.11±3.24, 11.5±3.39, 12.72±3.38. The change in heart rate was 84.22 ± 5.71 to 85.56 ± 5.81, 83.27 ± 5.72 to 69.05 ± 7.68, 84 ± 6.17 to 85.72±5.47, 82.33 ± 7.15 to 83.5±7.54. The change in average serum potassium levels 3.81 ± 0.39 to 3.79 ± 0.36, 3.79 ± 0.33 to 3.69 ± 0.22, 3.72 ± 0.35 to 4.08 ± 0.38, 3.74 ± 0.40 to 3.81 ± 0.27. Adverse events percentage was 38.88 percent, 36.11 percent, 36.11 percent and 13.88 percent in all 4 study group respectively. Conclusion: Amlodipine, Atenolol, Enalapril, and Losartan are equal efficacious to reduce SBP and DBP, whereas losartan is better tolerated and comparatively safer than amlodipine, atenolol and enalapril in patients with mild to moderate hypertension.
Authors and Affiliations
Ujwala P. Gawali
Keywords
Related Articles
- EP ID EP241965
- DOI -
- Views 62
- Downloads 0
F-DARA Algorithm For Time Slot Allocation In Internet of Things
In multi-user wireless video transmission over Internet of Things, to ensure that all video senders have sufficient transmission opportunity before their deadline expire is a challenging and key issue. Thus fuzzy based d...
Survey: Automated Process of Revaluation
To automate the process of submission of revaluation form we come up with the technology of ERevaluation. In this project we provide the modules as students and admin where the student will fill in the details for the ev...
A Review on Pattern Recognition Using Genetic Algorithms
Pattern recognition is a process to classify types of objects appearing in the input pattern. In computer science pattern recognition is the imposition of identity on input data, such as speech, images, or a stream of te...
Globalization: A Mathematical Biology & Topology Transformation
“The secrets of Globalization lie in Mathematics” is what this Paper really targets. Mathematicians like Abraham Robinson solved in 1960 the three hundred year old problem of infinitesimals in the belief that infinitesim...
Analyzing Human Traits Based on Hardy – Weinberg’s Principle
The H-W Equilibrium states that allele frequency does not change, outside force is required to change the frequency from generation to generation. If the gene frequencies are p and q, the genotype frequency will be p2 ,...